Advertisement

Topics

Innoviva Issues Press Statement

12:12 EDT 13 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Innoviva, Inc. (the “Company” or “Innoviva”) (NASDAQ: INVA) today issued the following statement. Innoviva has a track record of having a robust and continuing dialogue with its shareholders. On ...

Other Sources for this Article

Investor Contact:
Innoviva, Inc.
Eric d’Esparbes
Senior Vice President and Chief Financial Officer
650-238-9640
investor.relations@inva.com
or
Media Contacts:
Abernathy MacGregor
Patrick Tucker or Ina McGuinness
212-371-5999 or 213-630-6550
pct@abmac.com
ina@abmac.com

NEXT ARTICLE

More From BioPortfolio on "Innoviva Issues Press Statement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...